North Texas Research Forum 2025
Files
Download Full Text (4.0 MB)
Division
North Texas
Hospital
Medical City Fort Worth
Specialty
Internal Medicine
Document Type
Poster
Publication Date
2025
Keywords
rATG, bradycardia, renal transplant, end-stage renal disease, preeclampsia
Disciplines
Cardiology | Cardiovascular Diseases | Female Urogenital Diseases and Pregnancy Complications | Internal Medicine | Medicine and Health Sciences
Abstract
Rabbit antithymocyte globulin (rATG) is widely used for induction and treatment of acute T-cell mediated rejection in renal transplant patients. Bradycardia is reported as a rare side effect of this medication (citation). With the increasing number of transplanted kidneys in today's world, there is greater need to understand the adverse effects of these drugs in transplant recipients.. Here we report a case of symptomatic bradycardia in a renal transplant patient receiving rATG for acute T-cell mediated rejection.
Original Publisher
HCA Healthcare Graduate Medical Education
Recommended Citation
Mathew, John; DelPrincipe, Victor; Haci, Seline; Anand, Karthik; and Farhad, Rangina, "Bradycardia in a Renal Transplant Patient Receiving Rabbit Antithymocyte Globulin" (2025). North Texas Research Forum 2025. 22.
https://scholarlycommons.hcahealthcare.com/northtexas2025/22
Included in
Cardiology Commons, Cardiovascular Diseases Commons, Female Urogenital Diseases and Pregnancy Complications Commons, Internal Medicine Commons